EV/EBITDA

UnitedHealth Group’s current EV/EBITDA of 20.2x means that its enterprise value (market cap plus debt minus cash) is 20.2 times its earnings before interest, taxes, depreciation, and amortization — a measure of how richly the market values each dollar of operating profit.

This is slightly above the healthcare sector median of 19.8x, placing the stock at the 100th percentile among peers, meaning it is valued higher than all of them. The trend over the last eight quarters has been stable, with no year-over-year change available and a quarter-over-quarter decline of -1.4% from 20.5x to 20.2x. The combination of a premium valuation relative to the sector with a stable-to-slightly-declining trend suggests limited near-term upside from multiple expansion, but also no acute overvaluation risk if earnings hold. This metric supports the overall NEUTRAL verdict, as the high percentile rank signals elevated expectations, while the stable trend fails to provide a clear bullish or bearish catalyst.

Frequently Asked Questions

Closest Sector Peers